Cancer Research

The purpose of the study is to gather more information on the current use of Blue Light Cystoscopy^™ with Cysview^® in urologists' practices. This trial is a registry study for patients with bladder cancer who undergo cystoscopy. Cysview is an FDA approved drug imaging agent that is absorbed by malignant cells causing them to appear pink under blue light thus making them easier to see.

Open to enrollment

Posted By: Dr. T. Brian Willard

Posted Date: 5/20/2022

Location: Lexington Urology

Testing low dose tamoxifen for invasive breast cancer (LoTam) 

Open to enrollment. 

Posted By: Dr. Steven Madden

Posted Date: 4/29/2025

Location: Lexington Medical Cancer Center

A study to examine computerized training to improve concentration, learning new things, and remembering in breast cancer survivors. 

Open to enrollment. 

Posted By: Dr. Steven Madden

Posted Date: 5/23/2024

Location: Lexington Medical Cancer Center

This trial compares the recurrence-free interval (RFI) among patients with early stage, low-risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the current standard of care. 

Open to enrollment.

Posted By: Dr. Quillin Davis

Posted Date: 4/12/2024

Location: Lexington Medical Cancer Center

This phase III trial compares the effects of shorter chemotherapy-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.

Open to enrollment.

Posted By: Dr. Steven Madden

Posted Date: 8/28/2023

Location: Lexington Medical Cancer Center

Open to enrollment. 

Posted By: Dr. Steven Madden

Posted Date: 7/28/2023

Location: Lexington Medical Cancer Center

Open to enrollment.

Posted By: Dr. James Wells

Posted Date: 6/23/2023

Location: Lexington Medical Cancer Center

Posted By: Dr. Davis

Posted Date: 9/5/2019

Location: Lexington Medical Cancer Center

This study is testing the addition of high dose, targeted radiation to the usual treatment for locally advanced inoperable non-small cell lung cancer. 

Open to enrollment.

Posted By: Dr. Quillin Davis

Posted Date: 7/29/2024

Location: Lexington Medical Cancer Center

Open to enrollment 

Posted By: Dr. James Wells

Posted Date: 11/23/2020

Location: Lexington Oncology

 This trial is testing whether the addition of carboplatin chemotherapy to cabazitaxel chemotherapy with improve outcomes compared to cabazitaxel alone in people with castrate-resistant prostate cancer that has spread beyond the prostate to other parts of the body.

Open to enrollment.

Posted By: Dr. Scott Graupner

Posted Date: 4/29/2025

Location: Lexington Medical Cancer Center

Open to enrollment

Posted By: Dr. Quillin Davis

Posted Date: 11/1/2021

Location: Lexington Medical Cancer Center

This study is being done to answer the following question:  Can we lower the chance of your prostate cancer growing by adding Sunphenon® 90D (containing green tea catechins) by closely monitoring your prostate cancer?

Open to enrollment

Posted By: Dr. T. Brian Willard

Posted Date: 11/1/2021

Location: Lexington Urology